Variable | Estimates | n | Missing information |
---|---|---|---|
Median age, years (IQR) | 45 (37–52) | 4503 | 0 |
Female sex, n (%) | 864 (19) | 4503 | 0 |
Black race, n (%) | 58 (2) | 2879 | 1624 |
Body mass index, kg/m2 (IQR) | 22.9 (21.2–24.9) | 1394 | 3109 |
Current smoker, n (%) | 2110 (51) | 4154 | 349 |
Hypertension, n (%) | 619 (14) | 4503 | 0 |
Diabetes mellitus, n (%) | 225 (5) | 4503 | 0 |
Dyslipidemia, n (%) | 596 (13) | 4503 | 0 |
Cardiovascular disease, n (%) | 202 (5) | 4503 | 0 |
Hepatitis B coinfection, n (%) | 149 (3) | 4485 | 18 |
Hepatitis C coinfection, n (%) | 1006 (22) | 4495 | 8 |
Mode of HIV acquisition, n (%)a | 4503 | 0 | |
Homo/bisexual | 2650 (62) | ||
Heterosexual | 1176 (28) | ||
Injection drug use | 641 (15) | ||
Other/Unknown route | 290 (6) | ||
Duration of HIV infection, years (IQR) | 11.3 (5.1–19) | 4478 | 25 |
Prior AIDS (yes), n (%) | 900 (20) | 4503 | 0 |
Current ART regimen | 4503 | 0 | |
No treatment | 138 (3) | ||
NNRTI-based | 2381 (53) | ||
PI-based | 144 (3) | ||
Boosted PI-based | 1315 (29) | ||
Integrase inhibitors-based | 493 (11) | ||
Others | 32 (1) | ||
Nadir CD4 cell count (IQR) | 249 (129–369) | 4484 | 19 |
Current CD4 cell count (IQR) | 628 (450–830) | 4501 | 2 |
Current HIV infection status | 4503 | 0 | |
Suppression on Treatment | 4031 (90) | ||
No suppression (viral load > 50 copies) | 471 (10) |